Danaher beats Q2 profit estimates on strength in medical testing business
Go back to Danaher beats Q2 profit estimates on strength in medical testing business| Danaher Corp. (NYSE: DHR) | Delayed: 178.97 +0.78 (0.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $178.19 | 52 Week High | $102.79 | |||
| Open | $179.07 | 52 Week Low | $75.71 | |||
| Day High | $181.71 | P/E | 47.10 | |||
| Day Low | $177.07 | EPS | $3.80 | |||
| Volume | 4,149,818 | |||||

